Suppr超能文献

非小细胞肺癌完全切除术后五年生存者的长期生存及预后因素

Long-term survival and prognostic factors of five-year survivors with complete resection of non-small cell lung carcinoma.

作者信息

Okada Morihito, Nishio Wataru, Sakamoto Toshihiko, Harada Hiroaki, Uchino Kazuya, Tsubota Noriaki

机构信息

Department of Thoracic Surgery, Hyogo Medical Center for Adults, Kitaohji-cho 13-70, Akashi City 673-5885, Hyogo, Japan.

出版信息

J Thorac Cardiovasc Surg. 2003 Aug;126(2):558-62. doi: 10.1016/s0022-5223(03)00360-x.

Abstract

OBJECTIVE

We analyzed the long-term follow-up data on cancer-related death in 5-year survivors of complete resection of their non-small cell lung cancer and examined the prognostic factors having an impact on subsequent survival.

METHODS

Of 848 consecutive patients with proven primary non-small cell carcinoma who underwent complete removal of the primary tumor together with hilar and mediastinal lymph nodes, 421 patients (49.6%) survived 5 years or longer after the initial surgical treatment. Of all the data analyzed, only death related to cancer was treated as death.

RESULTS

The median follow-up of 5-year survivors was 84 months from the original treatment (range, 60 to 200 months). Their overall survival rate at 10 years was 91.0%. Multivariable Cox analysis demonstrated that although advanced surgical-pathological stage (P =.0001), nodal involvement (P =.0245), male gender (P =.0313), and non-squamous type of the tumor (P =.0034) were significant, independent, unfavorable prognostic determinants in all patients, none of the variables investigated significantly influenced the long-term survival of 5-year survivors. The rate of recurrence beyond 5 years was much lower compared with that within 5 years. In contrast, the rate of occurrence of new malignancies was unchanged throughout the long-term postoperative period.

CONCLUSIONS

Among 5-year survivors of complete resection of non-small cell lung cancer, neither stage, nodal status, sex, nor histologic condition further affected subsequent survival, suggesting that the 5-year interval might be sufficient to declare that a patient with lung cancer has been cured.

摘要

目的

我们分析了非小细胞肺癌完全切除术后5年生存者的癌症相关死亡长期随访数据,并研究了影响后续生存的预后因素。

方法

在848例经证实的原发性非小细胞癌连续患者中,这些患者均接受了原发肿瘤连同肺门和纵隔淋巴结的完全切除,421例患者(49.6%)在初始手术治疗后存活5年或更长时间。在所有分析的数据中,仅将与癌症相关的死亡视为死亡。

结果

5年生存者从初始治疗开始的中位随访时间为84个月(范围60至200个月)。他们10年的总生存率为91.0%。多变量Cox分析表明,尽管在所有患者中,手术病理分期较晚(P = 0.0001)、有淋巴结受累(P = 0.0245)、男性(P = 0.0313)以及肿瘤为非鳞状类型(P = 0.0034)是显著的、独立的不良预后决定因素,但所研究的变量均未对5年生存者的长期生存产生显著影响。5年后的复发率远低于5年内的复发率。相比之下,新恶性肿瘤的发生率在整个术后长期内保持不变。

结论

在非小细胞肺癌完全切除术后的5年生存者中,分期、淋巴结状态、性别和组织学状况均不再进一步影响后续生存,这表明5年的时间间隔可能足以宣布肺癌患者已治愈。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验